Opioids for neonates receiving mechanical ventilation

R Bellù1, K A de Waal, R Zanini

  • 1Neonatal Intensive Care Unit, Ospedale "Manzoni" -Lecco, Via Eremo 9, Lecco, Italy, 23900. r.bellu@ospedale.lecco.it

Insights

Opioid analgesics may reduce pain in newborns on mechanical ventilation but evidence is limited. Routine use is not recommended; selective use based on pain indicators is advised, with morphine being safer than midazolam for sedation.

Area of Science:

  • Neonatal intensive care
  • Pediatric pharmacology
  • Pain management

Background:

  • Mechanical ventilation is a common, yet painful, procedure in neonatal intensive care units.
  • Newborn infants are highly sensitive to pain, which can negatively impact neurodevelopmental outcomes.
  • Effective pain management is crucial for improving clinical outcomes in neonates.

Purpose of the Study:

  • To evaluate the efficacy of opioid analgesics compared to placebo, no treatment, or other sedatives/analgesics.
  • To assess the impact of opioids on pain, duration of mechanical ventilation, mortality, growth, and neurodevelopmental outcomes in neonates.
  • To provide evidence-based recommendations for opioid use in mechanically ventilated newborns.

Main Methods:

  • Systematic review and meta-analysis of randomized and quasi-randomized controlled trials.
  • Searches conducted across major databases including Cochrane CENTRAL, MEDLINE, EMBASE, and CINAHL.
  • Data extraction and analysis performed independently by two reviewers using appropriate statistical models (fixed or random effects).

Main Results:

  • Opioid administration was associated with reduced pain scores (Premature Infant Pain Profile - PIPP) in neonates.
  • No significant differences were observed in mortality, duration of mechanical ventilation, or neurodevelopmental outcomes.
  • Very preterm infants receiving morphine experienced delays in achieving full enteral feeding.

Conclusions:

  • Insufficient evidence exists to support the routine use of opioids in mechanically ventilated newborns.
  • Opioids should be utilized selectively, guided by clinical judgment and pain assessment.
  • Morphine is considered a safer option for sedation compared to midazolam in this population.
Abstract

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...